Network-based Approach in Type 2 Diabetes and Its Cardiovascular Risk

Exclusion Criteria

• •Clinical Diagnosis of Type 2 Diabetes. In according to current guidelines, diabetes is diagnosed by evidence of impairing fast glucose (IFG) \> 7.0 mmol/L (\>125 mg/dl), post prandial glycemia \> 11.1 mmol/L (\>200 mg/dl), and evidence of glycated hemoglobin (HbA1c) \> 6.6%. Clinical and demographic characteristics of study population will be avaiable from datasets generated by physicians.
• •Clinical Diagnosis of macrovascular dysfunction.
• •Patients with known history of cancer, malignancy disorders, active infections, and chronic or immune-mediated diseases.